Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

Why there is a baby formula crisis and what can be done about it

The formula shortage may continue for months.

Axios

After baby formula recall, Abbott says it can restart production at Michigan site within 2 weeks of FDA approval

Abbott Laboratories said it could have some of its recalled infant formulas back on store shelves within eight to 10 weeks after the U.S. Food and Drug Administration gives its approval, though it’s unclear when that approval may come.

Chicago Tribune

Tainted baby-formula risk was seen months before Abbott’s recall

Federal inspectors spotted the potential for baby formula made at an Abbott Laboratories plant to become contaminated months before a recall that exacerbated a nationwide shortage, a government document shows.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

How Bad Government Policy is Fueling the Infant Formula Shortage

Trade restrictions and over-zealous FDA regulation are a big part of the problem, but there's more.

Reason

US parents swap and sell baby formula amidst country-wide shortage

A US-wide baby formula shortage forces frenzied parents into online groups to swap and sell to each other to keep their babies fed.

ABC News

Senator says Biden should consider Defense Production Act to boost baby formula supply

Regular and specialized baby formulas have been running low across the U.S. Sen. Kirsten Gillibrand says she will ask President Biden to consider using the Defense Production Act to boost production.

WEKU

Company says it could restart production of baby formula within weeks amid severe shortage

Joe Biden set to discuss the issue and ways to address the shortage with manufacturers

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

LOCALIZE IT: Ideas for local coverage of baby formula crisis

Parents across the U.S. are scrambling to find baby formula because supply disruptions and a massive safety recall have swept many leading brands off store shelves.

The Independent UK

EXPLAINER: What's behind the baby formula shortage?

Many parents are hunting for infant formula after a combination of short- and long-term problems hit the biggest U.S. brands

The Independent UK

Abbott says two months for baby formula to hit shelves amid US shortage

US manufacturer forced to close Michigan plant after reports of illness and death that prompted federal investigation

The Guardian - US

What's behind the US infant formula shortage – and how to make sure it doesn't happen again

A baby formula shortage has added to the woes of American parents already confronted with the pressures of raising an infant during a pandemic in a country ranked low for family-friendly policies.

The Conversation

Baby formula shortage leaves parents scrambling nationwide

A combination of product recalls, rising prices and supply chain issues have particularly affected the availability of formula

The Independent UK

US House panel sets hearing on baby formula shortage exacerbated by recall from Michigan plant

WASHINGTON — A U.S. House committee on Wednesday announced plans for a May 25 hearing on a national baby formula shortage fueled in part by a February recall by the manufacturer Abbot for products made at its Michigan plant.

Tribune News Service

Baby formula shortage forces parents to pay $120 for single can as Target, CVS and Walgreens limit sales

CVS and Walgreens are limiting customers to three toddler and infant formulas per purchase as the shortage worsens across the US

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

France 24

‘Hurt, angry, anxious, scared’: Converging crises lead to US baby formula shortage

Along with much of the globe, US consumers are reeling from a cost of living and supply-chain crisis. One example is a shortage of baby formula caused by a constellation of factors, from rampant inflation to a massive recall over safety concerns.

The Independent UK

Parents hunting for baby formula as shortage spans US

Parents across the U.S. are scrambling to find baby formula because of supply disruptions and a massive safety recall by manufacturer Abbott

Chicago Tribune

Parents struggle with baby formula shortage. ‘It’s kind of scary’

For the first months of her life, Ashley Strom’s daughter seemed uncomfortable much of the time — vomiting frequently, squirming with acid reflux and sleeping poorly.

Reason

America's Trade and Regulatory Policies Have Contributed to the Baby Formula Shortage

Why do we have tariffs on imported formula in the middle of a shortage?

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

‘It’s a nightmare’: baby formula shortage leaves US parents desperate

Strained supplies are further exacerbated after a recall by manufacturer Abbott, experts say

The Guardian - US

Be kind rewind: the unstoppable rise of ‘nicecore’ films and TV

From Coda to Everything Everywhere All at Once to Abbott Elementary, audiences have been rushing toward optimism but others should criticize at their peril

StockNews.com

3 Large-Cap Stocks Rated 'Strong Buy' to Snatch-Up in May

Since the persistent Ukraine-Russia war, rising inflationary pressures, and Fed's upcoming interest rate hikes are expected to keep the stock market volatile in the near term, investors seek opportunities to invest in large-cap stocks, which hold the potential to generate relatively stable returns. So, we think it could be wise…

Benzinga

What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings

Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organically, with Nutrition growing 8%

Benzinga

Abbott Clocks Q1 COVID-19 Test Sales Of $3.3B, Reaffirms FY22 EPS Outlook

Abbott Laboratories (NYSE:ABT) has reported Q1 FY22 adjusted EPS of $1.73, up 31.1% Y/Y, better than the consensus of $1.47 and the management guidance of $1.50. Q1 sales of $11.9 billion increased 13.8% on a reported basis and 17.5% on an organic basis, beating the consensus of $11.02 billion. Worldwide sales, excluding…

The Independent UK

Baby formula shortage: What is causing supply issue and which stores are rationing products?

Out-of-stock per centages reached higher than 40 per cent in seven states in first week of April

The Guardian - US

Baby formula shortages hit stores across US with some rationing supplies

Product recalls after illnesses and deaths linked to powdered infant formula products combine with supply chain problems

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.